Effects of dietary supplementation with betaine on a nonalcoholic steatohepatitis (NASH) mouse model

Journal of Nutritional Science and Vitaminology

Volumn 58, Issue 5, 2012, Pages 371-375

  Kawakami, Sakura ^a   Han, Kyu Ho ^a   Nakamura, Yumi ^a   Shimada, Ken Ichiro ^b   Kitano, Tomoko ^b   Aritsuka, Tsutomu ^c   Nagura, Taizo ^a   Ohba, Kiyoshi ^a   Nakamura, Kimihide ^a   Fukushima, Michihiro ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b Technology and Research Development Division   (Japan)

^c Hokkaido Tokachi Area Regional Food Processing Technology Center   (Japan)

Author keywords

Betaine; Fat accumulation in liver; Hepatic steatosis; Nonalcoholic steatohepatitis (NASH) model mice

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETAINE; GLUTATHIONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BODY WEIGHT; CHEMICAL ANALYSIS; COLORIMETRY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD INTAKE; HISTOPATHOLOGY; LIGHT DARK CYCLE; LIPID DIET; LIPID STORAGE; LIVER HISTOLOGY; LIVER WEIGHT; MALE; MOUSE; NECROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; SPECTROFLUOROMETRY;

ALANINE TRANSAMINASE; ANIMALS; BETAINE; BODY WEIGHT; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY LIVER; GLUTAMYL AMINOPEPTIDASE; GLUTATHIONE; HEPATOCYTES; LIVER; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; TRIGLYCERIDES;

BETA VULGARIS SUBSP. VULGARIS; MUS; NEPTUNIA;

EID: 84872702829     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.58.371     Document Type: Note

References (20)

1. Schwahn BC, Wang XL, Mikael LG, Wu Q, Cohn J, Jiang H, Maclean KN, Rozen R. 2007. Betaine supplementation improves the atherogenic risk factor profi le in a transgenic mouse model of hyperhomocysteinemia. Atherosclerosis 195: e100-e107.
2. Duvnjak M, Lerotič I, Barsič N, Tomasič V, Virovič Jukič L, Velagič V. 2007. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 13: 4539-4550.
3. Yeh MM, Brunt EM. 2007. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 128: 834-847.
4. Farrell GC, Larter CZ. 2006. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (Suppl 1): S99-112.
5. Day CP, James OF. 1998. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
6. Ji C, Kaplowitz N. 2003. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124: 1488-1499.
7. National Research Council. 1985. Guide for the Care and Use of Laboratory Animals. National Institutes of Health Publication no. 85-23, revised ed. National Academy of Sciences, Washington, DC.
8. Cohn VH, Lyle JA. 1966. Fluorometric assay for glutathione. Anal Biochem 14: 434-440.
9. Fujii M, Shibazaki Y, Wakamatsu K, Honma T, Hashiguchi T, Sakurai M, Furuuchi M, Nishimura N, Suzuki K, Ichida T, Yoneyama H. 2012. A novel murine model recapitulates the pathogenesis of human non-alcoholic steatohepatitis (NASH) and NASH-related hepatocellular carcinoma. Digestive Disease Week Poster Su1958, program p. 347.
10. Okada T, Kawakami S, Nakamura Y, Han KH, Ohba K, Aritsuka T, Uchino H, Shimada K, Sekikawa M, Ishii H, Fukushima M. 2011. Amelioration of D-galactosamine- induced acute liver injury in rats by dietary supplementation with betaine derived from sugar beet molasses. Biosci Biotechnol Biochem 75: 1335-1341.
11. Kwon DY, Jung YS, Kim SJ, Park HK, Park JH, Kim YC. 2009. Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. J Nutr 139: 63-68.
12. Shi QZ, Wang LW, Zhang W, Gong ZJ. 2010. Betaine inhibits Toll-like receptor 4 expression in rats with ethanol-induced liver injury. World J Gastroenterol 16: 897-903.
13. Kim SK, Kim YC. 2005. Effects of betaine supplementation on hepatic metabolism of sulfur-containing amino acids in mice. J Hepatol 42: 907-913.
14. Mudd SH, Poole JR. 1975. Labile methyl balances for normal humans on various dietary regiments. Metabolism 24: 721-735.
15. Avila MA, Berasain C, Torres L, Martín-Duce A, Corrales FJ, Yang H, Prieto J, Lu SC, Caballería J, Rodés J, Mato JM. 2000. Reduced abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 33: 907-914.
16. Evans PJ, Whiteman M, Tredger JM, Halliwell B. 1997. Antioxidant properties of S-adenosyl-L-methionine: a proposed addition to organ storage fl uids. Free Radic Biol Med 23: 1002-1008.
17. Kathirvel E, Morgan K, Nandgiri G, Sandoval BC, Caudill MA, Bottiglieri T, French SW, Morgan TR. 2010. Betaineimproves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. Am J Physiol Gastrointest Liver Physiol 299: G1068-1077.
18. Yao ZM, Vance DE. 1988. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 263: 2998-3004.
19. Ridgway ND, Vance DE. 1988. Kinetic mechanism of phosphatidylethanolamine N-methyltransferase. J Biol Chem 263: 16864-16871.
20. Olthof MR, Vliet TV, Verhoef P, Zock PL, Katan MB. 2005. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomized, placebo-controlled studies in healthy humans. PLoS Med 2: 446-456.